When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BLUE - Bluebird bio Can Restart Halted Clinical Trials
bluebird bio Inc.
The Food and Drug Administration (FDA) has told bluebird bio (NASDAQ: BLUE) it can resume trials of its experimental gene therapy, LentiGlobin, after it determined the therapy wasn't responsible for a rare case of cancer diagnosed in a trial participant earlier this year.
IMAGE SOURCE: GETTY IMAGES.
Using a lentiviral vector, LentiGlobin inserts a modified gene in patients that allows them to produce enough adult hemoglobin to potentially eliminate or significantly reduce the need for transfusions.